Industry News
Tension On Gut Muscles Induces Cell Invasion In Zebrafish Intestine, Mimicking Cancer Metastasis, Penn Study Finds
Sep 11, 2012
The stiffness of breast tissue is increasingly recognized as an important factor explaining the onset of breast cancer. Stiffening induces molecular changes that promote cancerous behavior in cells. Bioengineering studies have found that breast cancer cells grown on a 3-D gel have enhanced cell replication and decreased organization as rigidity increases... Read More
Marijuana Use Linked To Testicular Cancer
Sep 10, 2012
Regular marijuana usage has been linked to a higher risk of testicular cancer, researchers from the University of California have revealed... Read More
Marijuana Use Linked To Testicular Cancer
Sep 10, 2012
Regular marijuana usage has been linked to a higher risk of testicular cancer, researchers from the University of California have revealed... Read More
Brain Radiation After Lung Cancer Treatment Reduces Risk Of Cancer Spreading
Sep 10, 2012
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago Multidisciplinary Symp... Read More
Experimental Regimen Treatment Provides Equivalent Survival Rate to Standard Chemotherapy in Late-Stage Lung Cancer Patients
Sep 10, 2012
Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab followed by bevacizumab (Pac+Cb+B) in patients with advanced non-squamous non-small cell lung cancer (NS-NSCLC), according to research presented at the 2012 Chicago Multidisciplinary ... Read More
Adding Bavituximab To Second-Line Chemotherapy Doubles Response Rate In Late-Stage Lung Cancer Patients
Sep 10, 2012
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) patients who have already received one prior chemotherapy regimen, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology... Read More
Experimental Regimen Treatment Provides Equivalent Survival Rate to Standard Chemotherapy in Late-Stage Lung Cancer Patients
Sep 10, 2012
Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab followed by bevacizumab (Pac+Cb+B) in patients with advanced non-squamous non-small cell lung cancer (NS-NSCLC), according to research presented at the 2012 Chicago Multidisciplinary ... Read More
Brain Radiation After Lung Cancer Treatment Reduces Risk Of Cancer Spreading
Sep 10, 2012
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago Multidisciplinary Symp... Read More
Stage I NSCLC Patients Who Receive Radiation Therapy Are Surviving Longer
Sep 10, 2012
Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from 20 percent to 16 percent, respectively, when comparing the two eras evaluated, 1999-2003 and 2004-2008, according to detailed analysis of the SEER-17 (Sur... Read More
Hispanic/Latino Non-Small Cell Lung Cancer Patients Have Higher Overall Survival Than Non-Hispanic White Patients
Sep 10, 2012
Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival compared to non-Hispanic white patients, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology... Read More
Previous Page Next Page